167 related articles for article (PubMed ID: 11008484)
1. Cyclic nucleotide phosphodiesterases: relating structure and function.
Francis SH; Turko IV; Corbin JD
Prog Nucleic Acid Res Mol Biol; 2001; 65():1-52. PubMed ID: 11008484
[TBL] [Abstract][Full Text] [Related]
2. Effects of cyclic nucleotide phosphodiesterases (PDEs) on mitochondrial skeletal muscle functions.
Tetsi L; Charles AL; Paradis S; Lejay A; Talha S; Geny B; Lugnier C
Cell Mol Life Sci; 2017 May; 74(10):1883-1893. PubMed ID: 28039524
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding.
Huai Q; Wang H; Zhang W; Colman RW; Robinson H; Ke H
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9624-9. PubMed ID: 15210993
[TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotide phosphodiesterases in Drosophila melanogaster.
Day JP; Dow JA; Houslay MD; Davies SA
Biochem J; 2005 May; 388(Pt 1):333-42. PubMed ID: 15673286
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a catalytic ligand bridging metal ions in phosphodiesterases 4 and 5 by molecular dynamics simulations and hybrid quantum mechanical/molecular mechanical calculations.
Xiong Y; Lu HT; Li Y; Yang GF; Zhan CG
Biophys J; 2006 Sep; 91(5):1858-67. PubMed ID: 16912214
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A.
Vasta V; Shimizu-Albergine M; Beavo JA
Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19925-30. PubMed ID: 17172443
[TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use.
Bender AT; Beavo JA
Pharmacol Rev; 2006 Sep; 58(3):488-520. PubMed ID: 16968949
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.
Lugnier C
Pharmacol Ther; 2006 Mar; 109(3):366-98. PubMed ID: 16102838
[TBL] [Abstract][Full Text] [Related]
9. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
[TBL] [Abstract][Full Text] [Related]
10. Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions.
Francis SH; Blount MA; Corbin JD
Physiol Rev; 2011 Apr; 91(2):651-90. PubMed ID: 21527734
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
12. cGMP: a unique 2nd messenger molecule - recent developments in cGMP research and development.
Friebe A; Sandner P; Schmidtko A
Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):287-302. PubMed ID: 31853617
[TBL] [Abstract][Full Text] [Related]
13. Functional Consequences of CFTR Interactions in Cystic Fibrosis.
Ramananda Y; Naren AP; Arora K
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542363
[TBL] [Abstract][Full Text] [Related]
14. Co-treatment of Naringenin and Ketoprofen-RGD Suppresses Cell Proliferation via Calmodulin/PDE/cAMP/PKA Axis Pathway in Leukemia and Ovarian Cancer Cells.
Afshari H; Noori S; Shokri B; Zarghi A
Iran J Pharm Res; 2023; 22(1):e136131. PubMed ID: 38116560
[TBL] [Abstract][Full Text] [Related]
15. Subcellular second messenger networks drive distinct repellent-induced axon behaviors.
Baudet S; Zagar Y; Roche F; Gomez-Bravo C; Couvet S; Bécret J; Belle M; Vougny J; Uthayasuthan S; Ros O; Nicol X
Nat Commun; 2023 Jun; 14(1):3809. PubMed ID: 37369692
[TBL] [Abstract][Full Text] [Related]
16. The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches.
Lugnier C
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142518
[TBL] [Abstract][Full Text] [Related]
17. Tadalafil and Steroid Hormones Interactions in Adipose, Bone and Prostate Tissues: Focus on Translational Perspectives.
Greco EA; Antinozzi C; Di Luigi L; Aversa A; Sgrò P
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457011
[TBL] [Abstract][Full Text] [Related]
18. Weighted Gene Coexpression Network Analysis in Mouse Livers following Ischemia-Reperfusion and Extensive Hepatectomy.
Liu W; Shi Y; Cheng T; Jia R; Sun MZ; Liu S; Liu Q
Evid Based Complement Alternat Med; 2021; 2021():3897715. PubMed ID: 35003298
[TBL] [Abstract][Full Text] [Related]
19. Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway.
Tettey A; Jiang Y; Li X; Li Y
Front Pharmacol; 2021; 12():767002. PubMed ID: 34867394
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
